Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

BACKGROUND: A randomised phase 2 trial of trimodality with or without induction chemotherapy (IC) in oesophageal cancer (EC) patients showed no advantage in overall survival (OS) or pathologic complete response rate. To identify subsets that might benefit from IC, a secondary analysis was done. METH...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Shimodaira, Yusuke, Slack, Rebecca S, Harada, Kazuto, Chen, Hsiang-Chun, Sagebiel, Tara, Bhutani, Manoop S, Lee, Jeffrey H, Weston, Brian, Elimova, Elena, Lin, Quan, Amlashi, Fatemeh G, Mizrak Kaya, Dilsa, Blum, Mariela A, Roth, Jack A, Swisher, Stephen G, Skinner, Heath D, Hofstetter, Wayne L, Rogers, Jane E, Mares, Jaennette, Thomas, Irene, Maru, Dipen M, Komaki, Ritsuko, Walsh, Garrett, Ajani, Jaffer A
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2018
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808035/
https://ncbi.nlm.nih.gov/pubmed/29235564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.423
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares